UK markets close in 5 minutes

Century Therapeutics, Inc. (IPSC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9750+0.0050 (+0.17%)
As of 11:25AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-127,444
-136,673
-130,932
-95,824
-53,575
Depreciation & amortisation
6,653
13,044
8,440
3,748
1,402
Stock-based compensation
9,573
14,622
10,669
4,662
876
Change in working capital
122,180
9,380
123,945
-2,797
4,862
Accounts payable
-863
-2,361
-4,788
-1,848
2,062
Other working capital
-28,449
-102,084
-16,552
-133,972
-51,094
Other non-cash items
1,646
-1,102
1,930
1,209
444
Net cash provided by operating activities
12,608
-88,348
14,052
-89,002
-41,269
Cash flows from investing activities
Investments in property, plant and equipment
-41,057
-13,736
-30,604
-44,970
-9,825
Purchases of investments
-245,551
-209,034
-254,000
-330,034
-49,860
Sales/maturities of investments
257,151
283,902
271,476
76,666
41,650
Other investing activities
-
-
-
-
-4,722
Net cash used for investing activities
-29,457
61,132
-13,128
-298,338
-22,757
Cash flows from financing activities
Debt repayment
-
-10,241
0
-
-
Common stock issued
27,146
516
27,158
221,615
0
Other financing activities
-
-
-
34,226
37,956
Net cash used provided by (used for) financing activities
27,169
-9,725
27,158
417,774
47,690
Net change in cash
10,320
-36,941
28,082
30,434
-16,336
Cash at beginning of period
103,009
86,244
58,162
27,728
44,064
Cash at end of period
113,329
49,303
86,244
58,162
27,728
Free cash flow
Operating cash flow
12,608
-88,348
14,052
-89,002
-41,269
Capital expenditure
-41,057
-13,736
-30,604
-44,970
-9,825
Free cash flow
-28,449
-102,084
-16,552
-133,972
-51,094